JINKO - Integrated Suite of Applications
The JINKO platform is NOVA’s unified in silico clinical trial simulation platform. With Artificial Intelligence and virtual populations at the heart of NOVA's innovative approach, the platform takes its name from the fortunate homonymic collision of the Japanese words for ‘artificial’ (äººå·¥, jinkÅ) and ‘population’ (äººå£, jinkÅ).
From discovery to market access
JINKO offers an integrated suite of applications from discovery to market access to handle complex multi-scale models in a fully whitebox environment. Each model component is seamlessly traceable from the model documentation back to each primary source of information to ensure full auditability.
JINKO’s modular design allows for a number of distinct use-case-oriented workflows, spanning from in-house model design, all the way to client-side interaction with the simulator.
Scenarios represent variations in disease, treatment options, and other study-related factors, that, combined with the virtual patient’s own characteristics, make up the input to a model simulation.
Each branch of a scenario corresponds to what would be an arm of a real-life clinical trial (including a potential control arm, where no modification is applied).